Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2017

View Archived Issues

Benitec Biopharma's BB-301 awarded orphan drug status in E.U. for OPMD

EC grants orphan drug designation to PBI-4050 for Alstrom syndrome

FDA, EMA accept Boehringer Ingelheim's BI-695501 for review

FDA grants fast track designation to aTyr Pharma's Resolaris

Global Blood Therapeutics begins enrollment in phase III study of GBT-440

Novel TyroSphere formulation of adapalene for topical acne therapy

Immunomedics presents new data for IMMU-132

Launch of the Coalition for Epidemic Preparedness Innovations

Promising results from final phase III trial of Cimzia in chronic plaque psoriasis

Takeda and Ovid collaborate on TAK-935 for rare pediatric epilepsies

aTyr Pharma provides overview of ongoing projects

NIAID initiates phase I trial of VRC07-523LS

Lilly to acquire CoLucid Pharmaceuticals

Mallinckrodt reaches agreement with FTC over Synacthen Depot

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Malaria vaccine using genetically engineered Plasmodium falciparum parasites tested in humans

Exelixis discovers new S1P1 and S1P5 receptor agonists

SignalChem Lifesciences describes novel carbonic anhydrase 9, 12 inhibtors

Bioblast Pharma releases results of phase IIa study of trehalose in SCA3 patients

Academia Sinica discloses new glucagon-like peptide 1 modulators

Redx Pharma discovers new compounds promoting interferon alpha production

AstraZeneca presents novel CDK9/cyclin T1 inhibitors

Matrine derivative YF-18 demonstrates therapeutic potential in models of lung cancer

FDA awards rare pediatric disease designation to TXA-127 from Tarix Orphan

HUYA Bioscience enters strategic collaboration with CAS Innovation

Catabasis describes development, structure and plans for CAT-5571

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...